Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer (Q34181456)

31 July 2017

title

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer (English)

1 reference

31 July 2017

1 reference

1 reference

1 reference

10

Rachel Schiff

1 reference

31 July 2017

C Kent Osborne

1

1 reference

31 July 2017

Valerie Bardou

2

1 reference

31 July 2017

Torsten A Hopp

3

1 reference

31 July 2017

Gary C Chamness

4

1 reference

31 July 2017

Susan G Hilsenbeck

5

1 reference

31 July 2017

Suzanne A W Fuqua

6

1 reference

31 July 2017

Jiemin Wong

7

1 reference

31 July 2017

D Craig Allred

8

1 reference

31 July 2017

Gary M Clark

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of the National Cancer Institute

31 July 2017

published in

1 reference

31 July 2017

volume

95

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

353-361

1 reference

Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Nuclear receptor coregulators: cellular and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Molecular markers for predicting response to tamoxifen in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Tamoxifen resistant breast cancer: coregulators determine the direction of transcription by antagonist-occupied steroid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

S-phase fraction and breast cancer--a decade of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

Molecular determinants for the tissue specificity of SERMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.5.353

21 January 2018

Identifiers

DOI

10.1093/JNCI/95.5.353

1 reference

31 July 2017

1 reference